Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Coldna Syrup is a combination pharmaceutical product developed and manufactured by Agron Remedies, typically used for the symptomatic relief of common cold, fever, and allergic rhinitis. It contains three active ingredients: paracetamol (acetaminophen), which acts as an analgesic and antipyretic by inhibiting prostaglandin synthesis; phenylephrine, a sympathomimetic amine that acts as a nasal decongestant by stimulating alpha-adrenergic receptors to cause vasoconstriction; and chlorpheniramine maleate, a first-generation antihistamine that blocks H1 receptors to alleviate symptoms like sneezing, itching, and watery eyes. As a product of Agron Remedies, a company focused on generic formulations and PCD (Proprietary Cantt. Distributor) franchises, Coldna Syrup is marketed as a branded generic rather than a novel clinical-stage candidate.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorpheniramine maleate + paracetamol + phenylephrine.